ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,000.00
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      82.275
      -0.01%
      Bitcoin
      67,819.08
      -0.50%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. PTC Therapeutics Inc (PTCT)

      7. PTC Therapeutics Inc (PTCT) Financials

      PTC Therapeutics Inc

      PTC Therapeutics Inc (PTCT)

      NASDAQ
      32.63
      -0.18
      (-0.55%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      32.63
      0.01
      (0.03%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      PTC Therapeutics Inc Financial Summary

      The current PTCT market cap is 2.5B. The company's latest EPS is USD -8.1699 and P/E is -3.99.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 220.38M340.31M195.08M309.76M210.22M
      Operating Income -117.62M-211.94M-118.16M5.82M-45.45M
      Net Income -138.96M-198.88M-132.97M-155.79M-91.58M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 306.98M380.77M538.59M698.8M1.07B
      Operating Income -241.16M-431.77M-374.94M-473.31M-439.5M
      Net Income -251.58M-438.16M-523.9M-559.02M-626.6M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.61B1.34B1.26B1.9B1.79B
      Total Liabilities 2.07B1.92B1.93B2.71B2.68B
      Total Equity -457.56M-579.27M-670.81M-818.56M-893.92M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.62B2.21B1.94B1.71B1.9B
      Total Liabilities 1.03B1.73B1.94B2.05B2.71B
      Total Equity 594.33M481.98M1.44M-347.09M-818.56M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -29.49M-43.61M-58.13M-158.42M70.76M
      Investing -28.97M-52.72M-82.32M-176.74M-114.93M
      Financing 4.09M22.55M25.92M646.4M540k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -98.64M-194.07M-251.33M-356.65M-158.42M
      Investing -387.24M-561.55M219.18M290.18M-176.74M
      Financing 613.21M668.72M20.88M167.95M646.4M

      Stats and Ratios

      Market Cap 2.5B
      Price to Earnings Ratio -3.99
      Price to Sales Ratio 2.35
      Price to Cash Ratio 4.21
      Price to Book Ratio -3.06
      Dividend Yield -

      Share Statistics

      Shares Outstanding 76.7M
      Average Volume (1 week) 778.99k
      Average Volume (1 Month) 975.65k
      52 Week Change -17.43%
      52 Week High 42.14
      52 Week Low 17.53
      Spread (Intraday) 22.51 (41.3%)

      Company Info

      Company Name PTC Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.ptcbio.com
      Industry pharmaceutical preparations (2834)